HOME >> MEDICINE >> NEWS
Nitrosamines Play Important Role In Cancer Linked To Smoking

nitrosamines, more effective approaches toward prevention of tobacco-related cancers can be designed. Because lung cancer therapy is still largely unsuccessful, the use of chemical agents to inhibit the carcinogenicity of tobacco smoke--called chemoprevention--remains as a viable way to prevent cancer death in addicted smokers and ex-smokers, Hecht adds. Many agents have been tested in mice, and phase I clinical trials for the leading candidate, an isothiocyanate called PEITC, are being initiated.

# # # #

Researcher contact: Dr. Stephen S. Hecht,
612-624-7604 (phone); 612-626-5135 (fax);
hecht002@gold.tc.umn.edu (email);

or Coleen Southwell,
Director of Communications, University of Minnesota Cancer Center
612-626- 1107;
south011@tc.umn.edu

For a copy of an earlier release on Dr. Hecht's research on nitrosamines and environmental tobacco smoke, or a copy of this 45-page review, call Sally Pecor at 202-872-4451.


'"/>

Contact: Jim Bohning
j_bohning@acs.org
202/872-6041
American Chemical Society
2-Jun-1998


Page: 1 2

Related medicine news :

1. Important priorities for prevention and treatment of HIV/AIDS
2. Important information to consider about non-systemic cholesterol lowering agents
3. Important advances in the development of drug delivery vehicles
4. Immunosuppressive Treatment Is Important For Sufferers Of Rheumatoid Arthritis
5. Cancer in patients with hepatitis C
6. Olson family donates $1 million to Arizona Cancer Center
7. Cancer vaccines: A two-pronged attack?
8. Mayo Clinic Cancer Center receives SPORE grant for brain cancer research from NCI
9. ESMO and Imedex announce partnership for the World Congress on Gastrointestinal Cancer
10. UT Southwestern Moncrief Cancer Center is first in Texas to treat patients with TomoTherapy
11. Cancer researchers seek to predict tumor growth

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/24/2017)... ... 2017 , ... The California State University Institute for Palliative Care ... interested in palliative care education and research. The Symposium, “Innovate. Investigate. Educate: Advancing ... Diego on Sept. 28 and 29, 2017, on the campus of California State University ...
(Date:2/24/2017)... Lawn, NJ (PRWEB) , ... February 24, 2017 ... ... with robust marketing services, which specializes in thought leadership , media relations, ... marketing campaigns and services that will be powered through Act-On, an intuitive marketing ...
(Date:2/23/2017)... ... 2017 , ... The 89th Academy Awards will be celebrated this weekend, which ... Center Bunkum Award. We invite you to enjoy our 11th annual tongue-in-cheek “salute” to ... the Center for American Progress (CAP), for its report, Lessons From State Performance on ...
(Date:2/23/2017)... ... February 23, 2017 , ... Hamlin Dental Group and Dr. Hamid Reza, ... a raffle. Throughout the month of February, patients who visit Hamlin Dental Group will ... a dinner for two at the Cheesecake Factory. , Tickets are available for ...
(Date:2/23/2017)... ... February 23, 2017 , ... Pink Pig Publishing ... generations converge and explore the world from different perspectives. By providing a place ... to gain understanding, increase empathy, and find greater happiness. , "Our approach ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... 2017 Report analyzes the worldwide markets for Endodontic ... for the US, Canada , ... Asia-Pacific , Latin America , and ... the period 2015 through 2022. Also, a six-year historic analysis ... derived from primary and secondary research. Company profiles are primarily ...
(Date:2/24/2017)... , Feb. 23, 2017  This report analyzes the ... the following Products: Intermediates, Analytical, and ... report include Pharmaceuticals, and Agrochemicals. The report provides separate ... , Europe , and Rest of ... period 2015 through 2022. Also, a six-year historic analysis ...
(Date:2/24/2017)... 24, 2017  Xynomic Pharmaceuticals, Inc., an oncology drug ... has acquired exclusive worldwide rights to develop, manufacture ... inhibitor targeting hematological and solid tumors. ... and 2 clinical trials of Abexinostat in US, ... already been completed, demonstrating that Abexinostat is clinically ...
Breaking Medicine Technology:
Cached News: